TerminatedNot Applicable

The Impact of the Timing of Trigger on IVF Success

Stopped: Stopped due to lack of enrollement

United States29 participantsStarted 2016-11

Plain-language summary

The aim of this study is to examine the length of ovarian stimulation with the timing of trigger in an IVF cycle and its potential to impact patient outcomes.

Who can participate

Age range

26 Years – 44 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Planning to move forward with an IVF cycle * Have met the requirements of being a patient at CCRM Colorado * AMA: 39-44 years old And/or * DOR: AMH \< 1 \& FSH \>10 (age independent) Exclusion Criteria: * Contraindication for pregnancy * Have not fulfilled requirements for IVF cycle * Single gene couple or chromosomal rearrangement * Severe male factor or testicular surgical sperm removal (need sufficient sperm for ICSI) * One ovary * Uterine anomalies * Stage III or IV endometriosis * Explained recurrent miscarriage * PCO or PCOS * Using donor oocyte or gestational carrier

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Euploid Embryos: the percentage of euploid embryos produced as analyzed by comprehensive chromosomal screening, of total embryos tested

Timeframe: 4 weeks after egg retrieval

Trial details

NCT IDNCT02990949

SponsorColorado Center for Reproductive Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-05-09

View on ClinicalTrials.gov More Fertilization in Vitro trials